{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:24:17Z","timestamp":1747207457908,"version":"3.40.5"},"reference-count":9,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Bullous pemphigoid is the most common chronic recurrent autoimmune\nsubepidermal blistering disorder most prevalent in the geriatric population. It varies widely in clinical\npresentation ranging from tense bullae to intense generalized pruritus. It is immunologic in\norigin with the presence of IgG antibodies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Report:<\/jats:title>\n<jats:p>A 47-year-old female presented to the hospital with complaints of blisters in the lower\nlimbs, which she self managed with neem oil, after which the blisters occurred over the body.\nThe patient also experienced blisters over both upper and lower limbs, gluteal region, painful generalized\nulcers, necrotic patches, multiple erythematous blisters, ulcer erosions over bilateral legs\nand upper limbs with few lesions, which were foul-smelling and oozing. On the second day of admission,\nthe patient\u2019s CRP and ESR levels were tested and the levels were 33.5 and 35 mm\/hr, respectively.\nThe patient was treated with an injection of meropenem 1 g three times daily, dexamethasone\n4 mg once daily, and ofloxacin 400 mg once daily. On the third day of admission, the patient\ncomplained of leg swelling, and subsequently, D-Dimer levels were checked, which showed a\nvalue of 5,740 and was treated with an injection of enoxaparin 40 mg for the same throughout the\ncourse of the hospital stay A skin biopsy confirmed the diagnosis of bullous pemphigoid. The culture\ntest showed the growth of Klebsiella pneumonia and Acinetobacter baumani, which were resistant\nto most of the antibiotics. The patient was managed appropriately with modalities including\nantibiotics, anti-inflammatory agents, immunosuppressants, multivitamins, fluids, and albumin.\nThe patient responded well to the treatment without new lesions or fever spikes. There was the\npresence of necrotic patches of old lesions alone at the time of discharge.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This case report was done with the purpose of presenting an exemplary case of\nbullous pemphigoid aggravated by the application of neem oil and emphasizing the inappropriate\nuse of folk medicine in an autoimmune disease like bullous pemphigoid.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886317666220518091554","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T10:42:15Z","timestamp":1653043335000},"page":"379-382","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-aggravated Bullous Pemphigoid in a 47-year-old Asian Woman -\nA Case Report"],"prefix":"10.2174","volume":"18","author":[{"given":"Divyajayashree","family":"Nelramachandrakumar","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haritha","family":"Hariharan","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilvel","family":"Nagamanickam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sri Ramakrishna Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-5167","authenticated-orcid":true,"given":"Sam Johnson Udaya","family":"Chander J.","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","volume":"94","author":"Miyamoto D.","year":"2019","unstructured":"Miyamoto D.; Santi C.G.; Aoki V.; Maruta C.W.; Bullous pemphigoid. An Bras Dermatol 2019,94(2),133-146","journal-title":"An Bras Dermatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/0019-5154.182422","volume":"61","author":"Chowdhury J.","year":"2016","unstructured":"Chowdhury J.; Datta P.K.; Chowdhury S.N.; Das N.K.; A clinicopathological study of pemphigus in Eastern India with special reference to direct immunofluorescence. Indian J Dermatol 2016,61(3),288-294","journal-title":"Indian J Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"Joly P.","year":"2002","unstructured":"Joly P.; Roujeau J-C.; Benichou J.; A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002,346(5),321-327","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13256-020-02421-w","volume":"14","author":"Khaddour H.H.","year":"2020","unstructured":"Khaddour H.H.; Zaher D.; Kassem T.; Hasan A.; Aggressive refractory Pemphigus vulgaris that responded to plasmapheresis: A case report. J Med Case Reports 2020,14(1),109","journal-title":"J Med Case Reports"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/jdv.12366","volume":"28","author":"Stavropoulos P.G.","year":"2014","unstructured":"Stavropoulos P.G.; Soura E.; Antoniou C.; Drug-induced pemphigoid: A review of the literature. J Eur Acad Dermatol Venereol 2014,28(9),1133-1140","journal-title":"J Eur Acad Dermatol Venereol"},{"year":"2020","author":"Baigrie D.","key":"ref=6","unstructured":"Baigrie D.; Nookala V.; Bullous Pemphigoid StatPearls. Available from: 2020"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","volume":"5","author":"Kridin K.","year":"2018","unstructured":"Kridin K.; Ludwig R.J.; The growing incidence of bullous pemphigoid: Overview and potential explanations. Front Med (Lausanne) 2018,5,220","journal-title":"Front Med (Lausanne)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4140\/TCP.n.2013.455","volume":"28","author":"Spivey J.","year":"2013","unstructured":"Spivey J.; Nye A.M.; Bullous pemphigoid: Corticosteroid treatment and adverse effects in long-term care patients. Consult Pharm 2013,28(7),455-462","journal-title":"Consult Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bjd.13717","volume":"172","author":"Feliciani C.","year":"2015","unstructured":"Feliciani C.; Joly P.; Jonkman M.F.; Management of bullous pemphigoid: The european dermatology forum consensus in collaboration with the european academy of dermatology and venereology. Br J Dermatol 2015,172(4),867-877","journal-title":"Br J Dermatol"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220518091554","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204950\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220518091554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:06:40Z","timestamp":1691334400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204950\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886317666220518091554","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}